Correlation Between Vicore Pharma and CBrain AS
Can any of the company-specific risk be diversified away by investing in both Vicore Pharma and CBrain AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vicore Pharma and CBrain AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vicore Pharma Holding and cBrain AS, you can compare the effects of market volatilities on Vicore Pharma and CBrain AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vicore Pharma with a short position of CBrain AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vicore Pharma and CBrain AS.
Diversification Opportunities for Vicore Pharma and CBrain AS
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Vicore and CBrain is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Vicore Pharma Holding and cBrain AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on cBrain AS and Vicore Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vicore Pharma Holding are associated (or correlated) with CBrain AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of cBrain AS has no effect on the direction of Vicore Pharma i.e., Vicore Pharma and CBrain AS go up and down completely randomly.
Pair Corralation between Vicore Pharma and CBrain AS
Assuming the 90 days trading horizon Vicore Pharma Holding is expected to under-perform the CBrain AS. But the stock apears to be less risky and, when comparing its historical volatility, Vicore Pharma Holding is 2.32 times less risky than CBrain AS. The stock trades about -0.11 of its potential returns per unit of risk. The cBrain AS is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 20,200 in cBrain AS on August 26, 2024 and sell it today you would earn a total of 100.00 from holding cBrain AS or generate 0.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vicore Pharma Holding vs. cBrain AS
Performance |
| Timeline |
| Vicore Pharma Holding |
| cBrain AS |
Vicore Pharma and CBrain AS Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vicore Pharma and CBrain AS
The main advantage of trading using opposite Vicore Pharma and CBrain AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vicore Pharma position performs unexpectedly, CBrain AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CBrain AS will offset losses from the drop in CBrain AS's long position.| Vicore Pharma vs. Bavarian Nordic | Vicore Pharma vs. BioPorto | Vicore Pharma vs. Zaptec AS | Vicore Pharma vs. cBrain AS |
| CBrain AS vs. ChemoMetec AS | CBrain AS vs. Ambu AS | CBrain AS vs. Genmab AS | CBrain AS vs. Zealand Pharma AS |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |